Skip to main content

Hospitalized COVID-19 patients with cardiometabolic risk do not benefit from dapagliflozin

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
Hospitalized COVID-19 patients with cardiometabolic risk do not benefit from dapagliflozin

User login

Username

Password

Reset your password

Type	Lead	score